Whitney Culpepper, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4901 Gary Ave, Fairfield, AL 35064 Phone: 205-785-4343 |
Bradley Glenn Livingston, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7201 Aaron Aronov Dr, Fairfield, AL 35064 Phone: 205-923-4788 |
Dr. Trenton Jared Webb, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4901 Gary Ave, Fairfield, AL 35064 Phone: 205-785-4343 |
Timothy Mack Terrell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4901 Gary Ave, Fairfield, AL 35064 Phone: 205-785-4343 Fax: 205-785-4344 |
Mr. Arthur Boyd Ennis Sr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4901 Gary Ave, Fairfield, AL 35064 Phone: 205-785-4343 |
Dr. Mitchell Lewis Ennis I, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4901 Gary Ave, Fairfield, AL 35064 Phone: 205-785-4343 |
Zachary Martin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7201 Aaron Aronov Dr, Fairfield, AL 35064 Phone: 205-923-4788 |
Scott Carson Keith, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4901 Gary Ave, Fairfield, AL 35064 Phone: 205-785-4343 Fax: 205-785-4344 |
News Archive
Sounds, such as music and noise, are capable of reliably affecting individuals' moods and emotions, possibly by regulating brain dopamine, a neurotransmitter strongly involved in emotional behavior and mood regulation.
Holon, the new standard for healthcare interoperability, today announced its entree into the healthcare information technology vertical. Signaling our new direction is the Holon Brand. Holon: (Greek: holos, "whole") is something that is simultaneously a whole and a part, a system that is itself a part of a larger system and signifies the blending of proven technologies with actionable intelligence to measurably improve care.
Pharmaceuticals are often dosed according to patient weight or body size which means that a dose must be individually measured. In a new study, lead author Anthony Hatswell of Delta Hat Limited and University College London in the UK, shows that by optimizing drug dose sizes available, wastage can be cut by as much as 50 percent.
Researchers at the University of Georgia have created a new therapeutic for prostate cancer that has shown great efficacy in mouse models of the disease. They published their findings recently in the journal Nanomedicine: Nanotechnology, Biology and Medicine.
› Verified 1 days ago